LIPT1 and breast cancer: Fan et al. constructed a risk scoring system by using CRGs for ER+ early BC, showing that High expression of FDX1, LIAS, LIPT1, DLD, PDHB, and ATP7B and low expression of CDKN2A were related to better RFS 89.